Long-term Evaluation of Nasopharyngeal Airway in Hypotonia
Key facts
- Where
- Ann Arbor, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 3 and 23 years old?
Source: NCT06614582, who can take part
Where in United States
- University of MichiganAnn Arbor, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- University of Michigan
- Trial code
- NCT06614582
- Record updated
- 2 December 2025
- Original description
This research is studying the long term use of a nasal airway device (self-supporting nasopharyngeal airway; "ssNPA") in children with hypotonic upper airway obstruction to learn about its effectiveness and tolerability as a treatment for obstructive sleep apnea.Read full original descriptionShow less
This research is studying the long term use of a nasal airway device (self-supporting nasopharyngeal airway; "ssNPA") in children with hypotonic upper airway obstruction to learn about its effectiveness and tolerability as a treatment for obstructive sleep apnea.
Inclusion: Children with Hypotonic Upper Airway Obstruction (HUAO) that took part in the original study (HUM00189669/NCT04846400 or HUM00220966/NCT05527652 trials); Willingness to continue device usage; Confirmed diagnosis of OSA (apnea/hypopnea index; AHI \> 10 or AHI \>5 with lowest oxygen level ≤75%); At least one symptom of OSA (such as frequent snoring, daytime sleepiness, or hyperactive/inattentive behaviors); Previous adenotonsillectomy (unless tonsillectomy not possible); Tonsil size 2+ or smaller.
Exclusion: Any medical reason why ssNPA therapy may not be suitable; Need for anticoagulative therapy; Active COVID 19 infections Moderate/severe tracheobronchomalacia; Bleeding disorder; Restrictive thoracic disorders; Participants that were non-compliant with the Self-Supporting Nasopharyngeal Airway (ssNPA) device during participation in the parent study listed above.